Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The polyepitope approach to DNA vaccination.

S G Smith1

  • 1ICRF Cancer Medicine Research Unit, St James's University Hospital, Beckett Street, Leeds, LS9 7TF, UK. mrpsgs@cancermed.leeds.ac.uk

Current Opinion in Molecular Therapeutics
|March 16, 2001
PubMed
Summary

Epitope-based vaccines, including DNA-encoded polyepitopes, offer a safer alternative to whole proteins. These vaccines stimulate robust immune responses against cancer and infectious diseases, potentially overcoming immune evasion.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of helminth co-infection and treatment on mycobacterial growth inhibition in UK migrants with TB infection.

IJTLD open·2025
Same author

The impact of mepolizumab on sleep impairment in CRSwNP: post hoc analyses of SYNAPSE and MUSCA.

Rhinology·2024
Same author

Mepolizumab improves sense of smell in severe chronic rhinosinusitis with nasal polyps: SYNAPSE.

Rhinology·2024
Same author

Evaluating treatment response to mepolizumab in patients with severe CRSwNP.

Rhinology·2023
Same author

Mepolizumab improves quality of life and reduces activity impairments in patients with CRSwNP.

Rhinology·2022
Same author

Early participant-reported symptoms as predictors of adherence to anastrozole in the International Breast Cancer Intervention Studies II.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Area of Science:

  • Immunology
  • Vaccinology
  • Molecular Biology

Background:

  • Epitopes, the smallest immunogenic parts of antigens, are key to developing safer vaccines.
  • Epitope-based vaccines avoid risks associated with whole proteins or genes.
  • Recent advances enable DNA-encoded epitopes in synthetic constructs to be processed and presented to CD8+ T-lymphocytes.

Purpose of the Study:

  • To review the background of epitope and polyepitope vaccination strategies.
  • To discuss recent findings on DNA-encoded polyepitope vaccines.
  • To explore future directions for enhancing polyepitope vaccine design.

Main Methods:

  • Review of existing literature on epitope and polyepitope vaccine development.
  • Analysis of data on DNA-encoded epitope processing and presentation.
  • Discussion of immune response mechanisms, including cytotoxic T-lymphocyte activation.

Main Results:

  • DNA-encoded epitopes can be effectively presented to CD8+ T-lymphocytes, even with unnatural flanking sequences.
  • Polyepitope vaccines can induce multiple cytotoxic T-lymphocyte responses against cancer and infectious diseases.
  • Targeting multiple antigens and HLA alleles can broaden immune response and prevent immune escape.

Conclusions:

  • DNA-encoded polyepitope vaccines represent a promising strategy for developing effective cancer and infectious disease vaccines.
  • These vaccines offer a way to induce broad and durable immunity, overcoming antigen loss variants.
  • Further research into polyepitope design holds potential for improved vaccine efficacy.

Related Experiment Videos